Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia
Alisa B. Lee‐Sherick(The Medical Center of Aurora), Douglas K. Graham(Emory University)
Cited by 44
Related Papers
Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
|Oncogene|2013|105
The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia
|JCI Insight|2016|78